Get the Stockscreener App
0.5902
3.08%
0.0066
After Hours:
.62
0.0298
+5.05%
Veru Inc stock is traded at $0.5902, with a volume of 1.39M.
It is up +3.08% in the last 24 hours and down -28.76% over the past month.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology and acute respiratory distress syndrome (ARDS). The company is also in the late stage development of certain drugs for management of breast and prostate cancers. It also has a sexual health program which includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in single segment and generates revenue from USA which is the key revenue generating market, South Africa and other regions.
See More
Previous Close:
$0.5836
Open:
$0.5839
24h Volume:
1.39M
Relative Volume:
2.08
Market Cap:
$86.76M
Revenue:
$15.93M
Net Income/Loss:
$-64.59M
P/E Ratio:
-0.4277
EPS:
-1.38
Net Cash Flow:
$-59.50M
1W Performance:
-16.72%
1M Performance:
-28.76%
6M Performance:
-54.42%
1Y Performance:
-43.51%
1-Day Range:
$0.575
$0.6299
1-Week Range:
$0.575
$0.72
52-Week Range:
$0.36
$1.92
Veru Inc Stock (VERU) Company Profile
Name
Veru Inc
Sector
Industry
Phone
(312) 595-9123
Address
2916 N. MIAMI AVENUE, MIAMI, FL
Compare VERU with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| VERU | 0.5902 | 86.76M | 15.93M | -64.59M | -59.50M | -1.38 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Veru Inc Stock (VERU) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-13-21 | Initiated | Jefferies | Buy |
| Feb-09-21 | Reiterated | H.C. Wainwright | Buy |
| Jan-21-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-20-19 | Initiated | Oppenheimer | Outperform |
| Jul-03-18 | Initiated | Maxim Group | Buy |
Veru Inc Stock (VERU) Latest News
SEC Form 424B4 filed by Onconetix Inc. - Quantisnow
Institutions along with retail investors who hold considerable shares inVeru Inc. (NASDAQ:VERU) come under pressure; lose 11% of holdings value - Simply Wall St
Veru’s (VERU) Outperform Rating Reiterated at Oppenheimer - Defense World
Veru (NASDAQ:VERU) Given "Outperform" Rating at Oppenheimer - MarketBeat
Oppenheimer maintains $5 target on VERU with positive outlook - Investing.com
Oppenheimer maintains $5 target on VERU with positive outlook By Investing.com - Investing.com Canada
Veru Announces Meta-analysis of Body Composition Data from - GlobeNewswire
Millennium Management LLC Increases Stake in Veru Inc - GuruFocus.com
Veru (NASDAQ:VERU) Stock Crosses Below 200 Day Moving Average – Should You Sell? - Defense World
Veru (NASDAQ:VERU) Share Price Crosses Below Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Veru to Present at ObesityWeek: Meta-Analysis of 4 Previous - GlobeNewswire
Veru to Present at ObesityWeek: Meta-Analysis of 4 Previous Randomized Clinical Trials that Support the Potential of Enobosarm to Optimize Weight Loss - StockTitan
Cisco To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Monday - MSN
Veru to Deliver Keynote Presentation on the Scientific - GlobeNewswire
Veru to Deliver Keynote Presentation on the Scientific Support for Enobosarm in Combination with GLP-1 Receptor Agonist to Preserve Muscle for Higher Quality Weight Loss at the 4th Edition of the World Obesity and Weight Management Congress - GlobeNewswire
Veru Inc (VERU) stock analysis: A simple moving average approach - US Post News
Hasbro, Inc. (HAS) Becoming More Attractive for Investors - Knox Daily
SS&C Technologies Holdings Inc (SSNC) rating initates by UBS - Knox Daily
Recent Insider Activity Suggests Potential Gains for Hyatt Hotels Corporation (H) - Knox Daily
Veru Inc (VERU) receives a Buy rating from B. Riley Securities - Knox Daily
Potential Price Increase for Castle Biosciences Inc (CSTL) After Recent Insider Activity - Knox Daily
Veru Inc (VERU) Stock: 52-Week Performance Insights and Trading Volume - The InvestChronicle
Buying Buzz: Veru Inc [VERU] Chief Corporate Officer FISCH HARRY purchases 4,000 shares of the company - Knox Daily
Veru Inc Inc. (VERU) Price Performance: The Role of Supply and Demand - The InvestChronicle
An analyst sees good growth prospects for Veru Inc (VERU) - SETE News
Veru (NASDAQ:VERU) shareholders are up 21% this past week, but still in the red over the last three years - Simply Wall St
Market Highlights: Veru Inc (VERU) Ends on a High Note at 0.91 - The Dwinnex
Veru Inc (VERU) Q3 2024 Earnings Call Highlights: Strategic Cost Management and Revenue Growth ... - Yahoo Finance
How should investors view Veru Inc (VERU)? - US Post News
The Potential Rise in the Price of Veru Inc (VERU) following insiders activity - Knox Daily
Sexual Wellness Market to Witness 4.7% CAGR by 2031 | SkyQuest Technology - Benzinga
PVG Asset Management Corp Invests $474,000 in Veru Inc. (NASDAQ:VERU) - Defense World
Veru Inc. (NASDAQ:VERU) Shares Purchased by Rhumbline Advisers - Defense World
Veru Inc. (NASDAQ:VERU) Position Boosted by Perceptive Advisors LLC - MarketBeat
Blair William & Co. IL Increases Stock Holdings in Veru Inc. (NASDAQ:VERU) - Defense World
A company insider recently bought 4,000 shares of Veru Inc [VERU]. Should You Buy? - Knox Daily
Examining Veru Inc (VERU) stock is warranted - US Post News
Bank of New York Mellon Corp Raises Stock Holdings in Veru Inc. (NASDAQ:VERU) - Defense World
Onconetix announces reverse stock split and equity issuances By Investing.com - Investing.com Canada
Onconetix reaches deal to defer $15 million debt to Veru - Investing.com
Veru Inc. modifies loan terms with Onconetix in amended agreement - Investing.com
Veru Inc. modifies loan terms with Onconetix in amended agreement By Investing.com - Investing.com Australia
Veru Inc (VERU) Stock: From Low to High in 52 Weeks - The InvestChronicle
Veru Inc. (NASDAQ:VERU) Shares Acquired by Choreo LLC - Defense World
Investing in Veru Inc (VERU): What You Must Know - Knox Daily
Metric Deep Dive: Understanding Veru Inc (VERU) Through its Ratios - The Dwinnex
Veru Inc (VERU) requires closer examination - US Post News
Prepare Yourself for Liftoff: Veru Inc (VERU) - SETE News
Veru Inc (VERU) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle
Veru Inc’s Market Journey: Closing Weak at 0.83, Down -3.80 - The Dwinnex
VERU Stock Sees Decline of Approximately -4.68% in Last Five Days - Knox Daily
Veru Inc Stock (VERU) Financials Data
Revenue
Net Income
Cash Flow
EPS
Veru Inc Stock (VERU) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| BARNETTE K GARY | Chief Scientific Officer |
May 24 '24 |
Buy |
1.34 |
5,000 |
6,696 |
5,000 |
| STEINER MITCHELL SHUSTER | President and CEO |
May 24 '24 |
Sale |
1.23 |
63,379 |
78,102 |
6,942,709 |
| STEINER MITCHELL SHUSTER | President and CEO |
May 22 '24 |
Sale |
1.39 |
6,504 |
9,018 |
7,006,388 |
| STEINER MITCHELL SHUSTER | President and CEO |
May 23 '24 |
Sale |
1.35 |
300 |
405 |
7,006,088 |
| FISCH HARRY | Chief Corporate Officer |
May 15 '24 |
Buy |
1.49 |
6,711 |
9,999 |
770,736 |
| STEINER MITCHELL SHUSTER | President and CEO |
May 15 '24 |
Sale |
1.50 |
84,021 |
125,813 |
7,100,746 |
| STEINER MITCHELL SHUSTER | President and CEO |
May 16 '24 |
Sale |
1.41 |
59,788 |
84,128 |
7,040,958 |
| STEINER MITCHELL SHUSTER | President and CEO |
May 17 '24 |
Sale |
1.32 |
28,066 |
36,988 |
7,012,892 |
4.27%
0.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):